United States Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: January 15, 2020 Report Code: GDMEMC0481DB-ST

Select Item

“What is covered in the report about the “United States Neurology Devices Market”?
GlobalData’s “United States Neurology Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Neurology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hydrocephalus shunts , Interventional Neuroradiology, Minimally Invasive Neurosurgery, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products and Radiosurgery Systems.

The United States Neurology Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Neurology Devices market.
• Global corporate-level profiles of key companies operating within the United States Neurology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

United States Neurology Devices is segmented as follows:
• Hydrocephalus shunts
• Interventional Neuroradiology
• Minimally Invasive Neurosurgery
• Neurological Diagnostic and Monitoring Equipment
• Neuromodulation Devices
• Neurosurgical Products
• Radiosurgery Systems

Key Reasons to Purchase
The United States Neurology Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Neurology Devices Market Outlook to 2025” report
• Boston Scientific Corp
• Medtronic plc
• Stryker Corp

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 26,400+ pipeline product profiles
• 52,400+ marketed product profiles
• 44,600+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 42,000+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table

1.1 List of Tables

Table 1: Neurology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 35

Table 2: Neurology Devices Market, United States, Category Contribution by Revenue ($m), 2018 38

Table 3: Neurology Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020 40

Table 4: Neurology Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025 41

Table 5: Neurology Devices Market, United States, Volume (Units), 2015-2025 43

Table 6: Neurology Devices Market, United States, Volume (Units), Historic, 2015-2020 45

Table 7: Neurology Devices Market, United States, Volume (Units), Forecast, 2021-2025 46

Table 8: Neurology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 48

Table 9: Hydrocephalus shunts Market, United States, Segment Contribution (%), 2018 50

Table 10: Hydrocephalus shunts Market, United States, Revenue ($m), USD Constant, 2015-2020 52

Table 11: Hydrocephalus shunts Market, United States, Revenue ($m), USD Constant, 2021-2025 52

Table 12: Hydrocephalus Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 54

Table 13: Hydrocephalus Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 54

Table 14: Hydrocephalus Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 56

Table 15: Hydrocephalus Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 56

Table 16: Hydrocephalus shunts Market, United States, Volume (Units), 2015-2020 58

Table 17: Hydrocephalus shunts Market, United States, Volume (Units), 2021-2025 58

Table 18: Hydrocephalus Catheters Market, United States, Volume (Units), 2015-2020 60

Table 19: Hydrocephalus Catheters Market, United States, Volume (Units), 2021-2025 60

Table 20: Hydrocephalus Valves Market, United States, Volume (Units), 2015-2020 62

Table 21: Hydrocephalus Valves Market, United States, Volume (Units), 2021-2025 62

Table 22: Hydrocephalus shunts Market, United States, Average Price ($), 2015-2020 63

Table 23: Hydrocephalus shunts Market, United States, Average Price ($), 2021-2025 63

Table 24: Hydrocephalus shunts Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 64

Table 25: Hydrocephalus shunts Market, United States, Company Share by Revenue ($m), USD Constant, 2018 65

Table 26: Interventional Neuroradiology Market, United States, Segment Contribution (%), 2018 68

Table 27: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2020 70

Table 28: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2021-2025 71

Table 29: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 73

Table 30: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 73

Table 31: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 75

Table 32: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 75

Table 33: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 77

Table 34: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 78

Table 35: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 80

Table 36: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 80

Table 37: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2020 82

Table 38: Interventional Neuroradiology Market, United States, Volume (Units), 2021-2025 83

Table 39: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2020 85

Table 40: Neurovascular Accessory Devices Market, United States, Volume (Units), 2021-2025 85

Table 41: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2020 87

Table 42: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2021-2025 87

Table 43: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2020 89

Table 44: Neurovascular Embolization Devices Market, United States, Volume (Units), 2021-2025 90

Table 45: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2020 92

Table 46: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2021-2025 92

Table 47: Interventional Neuroradiology Market, United States, Average Price ($), 2015-2020 93

Table 48: Interventional Neuroradiology Market, United States, Average Price ($), 2021-2025 94

Table 49: Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 95

Table 50: Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), USD Constant, 2018 97

Table 51: Minimally Invasive Neurosurgery Market, United States, Revenue ($m), USD Constant, 2015-2020 99

Table 52: Minimally Invasive Neurosurgery Market, United States, Revenue ($m), USD Constant, 2021-2025 99

Table 53: Minimally Invasive Neurosurgical Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 101

Table 54: Minimally Invasive Neurosurgical Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 101

Table 55: Minimally Invasive Neurosurgery Market, United States, Volume (Units), 2015-2020 103

Table 56: Minimally Invasive Neurosurgery Market, United States, Volume (Units), 2021-2025 103

Table 57: Minimally Invasive Neurosurgical Devices Market, United States, Volume (Units), 2015-2020 105

Table 58: Minimally Invasive Neurosurgical Devices Market, United States, Volume (Units), 2021-2025 105

Table 59: Minimally Invasive Neurosurgery Market, United States, Average Price ($), 2015-2020 106

Table 60: Minimally Invasive Neurosurgery Market, United States, Average Price ($), 2021-2025 106

Table 61: Minimally Invasive Neurosurgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 107

Table 62: Minimally Invasive Neurosurgery Market, United States, Company Share by Revenue ($m), USD Constant, 2018 109

Table 63: Neurological Diagnostic and Monitoring Equipment Market, United States, Segment Contribution (%), 2018 111

Table 64: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), USD Constant, 2015-2020 113

Table 65: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), USD Constant, 2021-2025 113

Table 66: Electrical Activity Testing Market, United States, Revenue ($m), USD Constant, 2015-2020 115

Table 67: Electrical Activity Testing Market, United States, Revenue ($m), USD Constant, 2021-2025 115

Table 68: ICP Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 117

Table 69: ICP Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 117

Table 70: Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2015-2020 119

Table 71: Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2021-2025 119

Table 72: Electrical Activity Testing Market, United States, Volume (Units), 2015-2020 121

Table 73: Electrical Activity Testing Market, United States, Volume (Units), 2021-2025 121

Table 74: ICP Monitoring Devices Market, United States, Volume (Units), 2015-2020 123

Table 75: ICP Monitoring Devices Market, United States, Volume (Units), 2021-2025 123

Table 76: Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2015-2020 124

Table 77: Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2021-2025 125

Table 78: Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 126

Table 79: Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2018 128

Table 80: Neuromodulation Devices Market, United States, Segment Contribution (%), 2018 131

Table 81: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 133

Table 82: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 134

Table 83: Neuromodulation Devices Market, United States, Volume (Units), 2015-2020 136

Table 84: Neuromodulation Devices Market, United States, Volume (Units), 2021-2025 137

Table 85: Neuromodulation Devices Market, United States, Average Price ($), 2015-2020 138

Table 86: Neuromodulation Devices Market, United States, Average Price ($), 2021-2025 139

Table 87: Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 140

Table 88: Neuromodulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 142

Table 89: Neurosurgical Products Market, United States, Segment Contribution (%), 2018 144

Table 90: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2020 146

Table 91: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2021-2025 146

Table 92: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 148

Table 93: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 148

Table 94: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2020 150

Table 95: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2021-2025 150

Table 96: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2020 152

Table 97: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2021-2025 152

Table 98: Neurosurgical Products Market, United States, Volume (Units), 2015-2020 154

Table 99: Neurosurgical Products Market, United States, Volume (Units), 2021-2025 154

Table 100: Dura Substitutes Market, United States, Volume (Units), 2015-2020 156

Table 101: Dura Substitutes Market, United States, Volume (Units), 2021-2025 156

Table 102: Neuroendoscopes Market, United States, Volume (Units), 2015-2020 158

Table 103: Neuroendoscopes Market, United States, Volume (Units), 2021-2025 158

Table 104: Neurosurgical Drills Market, United States, Volume (Units), 2015-2020 160

Table 105: Neurosurgical Drills Market, United States, Volume (Units), 2021-2025 160

Table 106: Neurosurgical Products Market, United States, Average Price ($), 2015-2020 161

Table 107: Neurosurgical Products Market, United States, Average Price ($), 2021-2025 162

Table 108: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 163

Table 109: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2018 165

Table 110: Radiosurgery Systems Market, United States, Segment Contribution (%), 2018 167

Table 111: Radiosurgery Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 169

Table 112: Radiosurgery Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 169

Table 113: Radiosurgery Systems Market, United States, Volume (Units), 2015-2020 171

Table 114: Radiosurgery Systems Market, United States, Volume (Units), 2021-2025 171

Table 115: Radiosurgery Systems Market, United States, Average Price ($), 2015-2020 172

Table 116: Radiosurgery Systems Market, United States, Average Price ($), 2021-2025 172

Table 117: Radiosurgery Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 173

Table 118: Radiosurgery Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2018 174

Table 119: Neurology Devices Market Pipeline Products 179

Table 120: Alkermes Acquires Rodin Therapeutics for up to USD950 Million 184

Table 121: Marmon Acquires 60% Stake in Colson Medical Companies from Colson Associates 186

Table 122: Neurolign Technologies Acquires Neuro Kinetics 188

Table 123: Integra LifeSciences Acquires Rebound Therapeutics 189

Table 124: PreCheck Health Services to Acquire LD Technology and Medical Screening for USD15 Million 190

Table 125: Integra LifeSciences Acquires Arkis Biosciences 191

Table 126: Pacira Pharma Acquires Myoscience 192

Table 127: Edwards Lifesciences Acquires CAS Medical Systems 193

Table 128: Smith & Nephew May Acquire NuVasive 195

Table 129: Daan Dohmen to Acquire OMRON Healthcare 196

Table 130: Integer Acquires Certain Assets of US BioDesign 197

Table 131: BrainsWay Acquires TMS Patent Portfolio from TMS Innovations 199

Table 132: Stryker Prices Public Offering of 1% Notes Due 2031 for USD826.2 Million 200

Table 133: Stryker Prices Public Offering of 0.75% Notes Due 2029 for USD881.3 Million 202

Table 134: Stryker Prices Public Offering of 0.25% Notes Due 2024 for USD936.4 Million 204

Table 135: Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027 206

Table 136: eNeura Raises USD5.9 Million in Debt funding 208

Table 137: Boston Scientific Raises USD1 Billion in Public Offering of 4.700% Notes Due 2049 209

Table 138: Boston Scientific Raises USD750 Million in Public Offering of 4.550% Notes Due 2039 211

Table 139: Boston Scientific Raises USD850 Million in Public Offering of 4.000% Notes Due 2029 213

Table 140: Boston Scientific Raises USD850 Million in Public Offering of 3.450% Notes Due 2024 215

Table 141: Boston Scientific Raises USD850 Million in Public Offering of 3.750% Notes Due 2026 217

Table 142: Helius Medical Technologies Prices Public Offering of Shares for USD1.7 Million 219

Table 143: Axonics Modulation Technologies Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD126.5 Million 221

Table 144: Axonics Modulation Technologies Plans to Raise up to USD200 Million in Public Offering of Securities 223

Table 145: NeuroOne Medical Technologies Raises USD0.25 Million in First Tranche of Private Placement of Shares 224

Table 146: Soleno Therapeutics Raises USD15.4 Million in Public Offering of Shares 225

Table 147: InspireMD Raises USD5 Million in Public Offering of Units 227

Table 148: Neuronetics Plans to Raise up to USD125 Million in Public Offering of Securities 229

Table 149: Silk Road Medical Raises USD190.7 Million in Public Offering of Shares 230

Table 150: Neuronetics Plans to Raise Funds through Public Offering of Shares 232

Table 151: Access Scientific Raises USD20 Million in Private Placement of Shares 233

Table 152: Cara Therapeutics Raises USD145.5 Million in Public Offering of Shares 234

Table 153: ElectroCore Plans to Raise up to USD50 Million in Public Offering of Securities 236

Table 154: NeuroOne Medical Technologies to Raise up to USD29 Million in Public Offering of Shares 237

Table 155: Nuvectra Plans to Raise up to USD25 Million in Public Offering of Shares 238

Table 156: ReShape Lifesciences to Raise USD8 Million in Private Placement of Common Stock 239

Table 157: MRI Interventions Raises USD7.5 Million in Private Placement of Shares 240

Table 158: Silk Road Medical Raises USD120 Million in IPO of Shares 242

Table 159: Neuroone Medical Technologies Raises USD0.6 Million in Private Placement 244

Table 160: Myomo Raises USD6.4 Million in Public Offering of Shares 245

Table 161: Stryker Plans to Raise Funds through Public Offering of Securities 247

Table 162: Neurometrix Plans to Raise up to USD25 Million in Public Offering of Securities 248

Table 163: GTX medical and NeuroRecovery Technologies Merge 249

Table 164: Pulse Therapeutics and ICHOR Vascular Merge 250

Table 165: BioSig Technologies Enters into Licensing Agreement with Mayo Clinic 251

Table 166: ImmersiveTouch Enters into Co-Marketing Agreement with Zimmer Biomet 252

Table 167: XRHealth Enters into Partnership with Magic Leap 253

Table 168: Children’s Specialized Hospital Enters into Co-Development Agreement with ATENTIV 254

Table 169: Kelyniam Global Enters into Distribution Agreement with Bioplate 255

Table 170: Cala Health Enters into Licensing Agreement with Partners Healthcare 256

Table 171: MRI Interventions Enters into Collaboration with Siemens Healthineers 257

Table 172: BrainsWay Enters into Option Agreement with Stanford University to License TMS Patents 258

Table 173: Eisai and Empatica Enter into a Co-Promotion Agreement for Embrace2 Device 259

Table 174: WeHealth by Servier Enters into Agreement with PathMaker Neurosystems 260

Table 175: Linden Capital Partners Acquires Collagen Matrix 261

Table 176: Concord Health Partners Invests in MIVI Neuroscience 263

Table 177: New Heritage Capital Invests in Rhythmlink International 264

Table 178: StimAire Raises Funds through Series A Financing 265

Table 179: Transverse Medical Raises USD0.14 Million in Venture Financing 266

Table 180: Elira (Elira Therapeutics) Secures USD0.973 Million in Venture Funding 267

Table 181: Potrero Medical Raises Additional USD5.4 Million in Venture Financing 268

Table 182: ShiraTronics Raises USD33 Million in Series A Financing 269

Table 183: Neuros Medical Raises USD2.4 Million in Venture Financing 271

Table 184: BrainCheck Raises USD8 Million in Series A Financing 272

Table 185: PhotoPharmics Raises USD6.6 Million in Venture Financing 273

Table 186: Cadence Neuroscience Raises USD15 Million in Series A Financing 274

Table 187: Zygood Raises USD0.1 Million in Venture Financing 275

Table 188: Sense Diagnostics Raises USD2.3 Million in Venture Financing 276

Table 189: Potrero Medical Raises USD11.7 Million in Venture Financing 277

Table 190: Longeviti Neuro Solutions Raises USD9.59 Million in Venture Financing 278

Table 191: Evren Technologies to Raise Funds through Venture Financing 279

Table 192: Seer (Seer Biosciences) Secures USD17.5 Million in Series C Funding 280

Table 193: Neurotrack Tech Raises USD21 Million in Series C Financing 281

Table 194: Deep Brain Innovations Raises USD0.39 Million in Venture Financing 283

Table 195: Cala Health Raises USD50 Million in Series C Financing 284

Table 196: Neural Analytics Raises USD22 Million in Series C Financing 287

Table 197: Carewave Medical Raises USD1.7 Million in Venture Financing 288

Table 198: Neuralink Raises USD39.31 Million in Venture Financing 289

Table 199: Paradromics Raises USD1.35 Million in Venture Financing 290

Table 200: Alcyone Lifesciences Raises USD1.7 Million in Venture Financing 291

Table 201: NovaSom Raises Additional USD0.8 Million in Venture Financing 292

Table 202: Liberate Medical Raises USD0.8 Million in Venture Financing 293

Table 203: Elira Raises USD0.9 Million in Venture Financing 294

Table 204: Neuro Kinetics Secures USD0.25 Million in Funding 295

Table 205: MIVI Neuroscience Raises USD3.2 Million in Venture Financing 296

Table 206: SPR Therapeutics Raises USD8 Million in Series C-1 Financing 297

Table 207: Croton Healthcare Secures USD0.325 Million in Funding 298

Table 208: SpineX Raises Funds through Seed Financing 299

Table 209: Mindstrong Raises Additional USD31 Million in Series B Venture Financing 300

Table 210: Total Number of Primary Research Participants, Neurology Devices Market, by Country 695

Figures

1.2 List of Figures

Figure 1: Neurology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 34

Figure 2: Neurology Devices Market, United States, Revenue Mix ($m), 2018 36

Figure 3: Neurology Devices Market, United States, Category Contribution (%), 2018 37

Figure 4: Neurology Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025 39

Figure 5: Neurology Devices Market, United States, Volume (Units), 2015-2025 42

Figure 6: Neurology Devices Market, United States, Volume (Units), Historic, 2015-2025 44

Figure 7: Neurology Devices Market, United States, Company Share (%) 2018 47

Figure 8: Hydrocephalus shunts Market, United States, Revenue Mix ($m), 2018 49

Figure 9: Hydrocephalus shunts Market, United States, Segment Contribution (%), 2018 50

Figure 10: Hydrocephalus shunts Market, United States, Revenue ($m), USD Constant, 2015-2025 51

Figure 11: Hydrocephalus Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 53

Figure 12: Hydrocephalus Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 55

Figure 13: Hydrocephalus shunts Market, United States, Volume (Units), 2015-2025 57

Figure 14: Hydrocephalus Catheters Market, United States, Volume (Units), 2015-2025 59

Figure 15: Hydrocephalus Valves Market, United States, Volume (Units), 2015-2025 61

Figure 16: Hydrocephalus shunts Market, United States, Company Share (%) 2018 65

Figure 17: Interventional Neuroradiology Market, United States, Revenue Mix ($m), 2018 66

Figure 18: Interventional Neuroradiology Market, United States, Segment Contribution (%), 2018 67

Figure 19: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2025 69

Figure 20: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 72

Figure 21: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 74

Figure 22: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 76

Figure 23: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 79

Figure 24: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 81

Figure 25: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2025 84

Figure 26: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2025 86

Figure 27: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2025 88

Figure 28: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2025 91

Figure 29: Interventional Neuroradiology Market, United States, Company Share (%) 2018 96

Figure 30: Minimally Invasive Neurosurgery Market, United States, Revenue ($m), USD Constant, 2015-2025 98

Figure 31: Minimally Invasive Neurosurgical Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 100

Figure 32: Minimally Invasive Neurosurgery Market, United States, Volume (Units), 2015-2025 102

Figure 33: Minimally Invasive Neurosurgical Devices Market, United States, Volume (Units), 2015-2025 104

Figure 34: Minimally Invasive Neurosurgery Market, United States, Company Share (%) 2018 108

Figure 35: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue Mix ($m), 2018 110

Figure 36: Neurological Diagnostic and Monitoring Equipment Market, United States, Segment Contribution (%), 2018 111

Figure 37: Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), USD Constant, 2015-2025 112

Figure 38: Electrical Activity Testing Market, United States, Revenue ($m), USD Constant, 2015-2025 114

Figure 39: ICP Monitoring Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 116

Figure 40: Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2015-2025 118

Figure 41: Electrical Activity Testing Market, United States, Volume (Units), 2015-2025 120

Figure 42: ICP Monitoring Devices Market, United States, Volume (Units), 2015-2025 122

Figure 43: Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share (%) 2018 127

Figure 44: Neuromodulation Devices Market, United States, Revenue Mix ($m), 2018 129

Figure 45: Neuromodulation Devices Market, United States, Segment Contribution (%), 2018 130

Figure 46: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 132

Figure 47: Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 135

Figure 48: Neuromodulation Devices Market, United States, Company Share (%) 2018 141

Figure 49: Neurosurgical Products Market, United States, Revenue Mix ($m), 2018 143

Figure 50: Neurosurgical Products Market, United States, Segment Contribution (%), 2018 144

Figure 51: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2025 145

Figure 52: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 147

Figure 53: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2025 149

Figure 54: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2025 151

Figure 55: Neurosurgical Products Market, United States, Volume (Units), 2015-2025 153

Figure 56: Dura Substitutes Market, United States, Volume (Units), 2015-2025 155

Figure 57: Neuroendoscopes Market, United States, Volume (Units), 2015-2025 157

Figure 58: Neurosurgical Drills Market, United States, Volume (Units), 2015-2025 159

Figure 59: Neurosurgical Products Market, United States, Company Share (%) 2018 164

Figure 60: Radiosurgery Systems Market, United States, Revenue Mix ($m), 2018 166

Figure 61: Radiosurgery Systems Market, United States, Segment Contribution (%), 2018 167

Figure 62: Radiosurgery Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 168

Figure 63: Radiosurgery Systems Market, United States, Volume (Units), 2015-2025 170

Figure 64: Radiosurgery Systems Market, United States, Company Share (%) 2018 174

Frequently asked questions

United States Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. in real time.

  • Access a live United States Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more